Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 71

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 71
---
 to the Merger Agreement, the performance of its obligations
thereunder and matters ancillary thereto. Acquirer has its executive offices located at 777 W. Main Street, Suite 900, Boise, ID 83702, and can be reached by phone at (208) 433-1200.

Poseidon Merger Sub I, Inc.

Merger Sub is a newly formed Delaware corporation and direct, wholly-owned subsidiary of Clearwater. Merger Sub was formed on January 3,
2025 under the name Poseidon Merger Sub I, Inc. solely for the purpose of engaging in the transactions contemplated by the Merger Agreement. Merger Sub has not carried on any business, conducted any operations or incurred any liabilities or
obligations, other than those incidental to its formation pursuant to the Merger Agreement, the performance of its obligations thereunder and matters ancillary thereto. Upon consummation of the Merger, Merger Sub will cease to exist. Merger Sub has
its executive offices located at 777 W. Main Street, Suite 900, Boise, ID 83702, and can be reached by phone at (208) 433-1200.

Poseidon Merger Sub II, LLC

Merger Sub II is a newly formed Delaware limited liability company and indirect, wholly-owned subsidiary of Clearwater.
Merger Sub II was formed on January 3, 2025 under the name Poseidon Merger Sub II, LLC solely for the purpose of engaging in the transactions contemplated by the Merger Agreement. Merger Sub II has not carried on any business, conducted any
operations or incurred any liabilities or obligations, other than those incidental to its formation pursuant to the Merger Agreement, the performance of its obligations thereunder and matters ancillary thereto. Upon consummation of the LLC Merger,
Merger Sub II will cease to exist. Merger Sub II has its executive offices located at 777 W. Main Street, Suite 900, Boise, ID 83702, and can be reached by phone at (208) 433-1200.

44

INFORMATION ABOUT THE SPECIAL MEETING General This Proxy Statement/Prospectus is first being mailed on or about March 20, 2025 and constitutes notice of the Special Meeting in conformity with the requirements of the DGCL and the Enfusion Bylaws (as defined below). This Proxy Statement/Prospectus is being provided to Enfusion Stockholders as part of a solicitation of proxies by the En